Production of antigen-specific human monoclonal antibodies comparison of mice carrying IgH/kappa or IgH/kappa/lambda transloci

Production of antigen-specific human monoclonal antibodies : comparison of mice carrying IgH/kappa or IgH/kappa/lambda transloci

Here we compare human monoclonal antibody (MAb) production from mouse strains that carry disruptions of their endogenous mouse IgH/IgK loci and harbor human IgM + Igkappa(BABkappa) or human IgM + Igkappa + IgA transloci (BABkappa,lambda). We found that whereas both strains proved effective for the i...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:BioTechniques. - 1991. - 33(2002), 3 vom: 11. Sept., Seite 680, 682, 684 passim
1. Verfasser: Magadán, S (VerfasserIn)
Weitere Verfasser: Valladares, M, Suarez, E, Sanjuán, I, Molina, A, Ayling, C, Davies, S L, Zou, X, Williams, G T, Neuberger, M S, Brüggemann, M, Gambón, F, Diaz-Espada, F, González-Fernandez, A
Format: Aufsatz
Sprache:English
Veröffentlicht: 2002
Zugriff auf das übergeordnete Werk:BioTechniques
Schlagworte:Comparative Study Journal Article Research Support, Non-U.S. Gov't Antibodies, Monoclonal Immunoglobulin M Immunoglobulin kappa-Chains
LEADER 01000caa a22002652c 4500
001 NLM12095852X
003 DE-627
005 20250203115621.0
007 tu
008 231222s2002 xx ||||| 00| ||eng c
028 5 2 |a pubmed25n0403.xml 
035 |a (DE-627)NLM12095852X 
035 |a (NLM)12238778 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Magadán, S  |e verfasserin  |4 aut 
245 1 0 |a Production of antigen-specific human monoclonal antibodies  |b comparison of mice carrying IgH/kappa or IgH/kappa/lambda transloci 
264 1 |c 2002 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 07.05.2003 
500 |a Date Revised 28.09.2018 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a Here we compare human monoclonal antibody (MAb) production from mouse strains that carry disruptions of their endogenous mouse IgH/IgK loci and harbor human IgM + Igkappa(BABkappa) or human IgM + Igkappa + IgA transloci (BABkappa,lambda). We found that whereas both strains proved effective for the isolation of antigen-specific IgM antibodies, many of the IgM MAbs elicited from BABkappa comprise human mu chains that are associated with mouse lambda chains. In contrast, BABkappa,lambda mice gave rise to fully functional, polymeric human IgM antibodies comprising both human IgH and human IgL chains. Therefore, the inclusion of a human Iglambda translocus (in addition to the human IgH + Igkappa transloci) not only diminishes problems of endogenous mouse Iglambda expression but also provides a strain of mice that yields fully human MAbs to a wide range of antigens, as witnessed by the isolation of MAbs to human blood cells, tumor cell lines, and an immunoglobulin idiotype 
650 4 |a Comparative Study 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 7 |a Antibodies, Monoclonal  |2 NLM 
650 7 |a Immunoglobulin M  |2 NLM 
650 7 |a Immunoglobulin kappa-Chains  |2 NLM 
700 1 |a Valladares, M  |e verfasserin  |4 aut 
700 1 |a Suarez, E  |e verfasserin  |4 aut 
700 1 |a Sanjuán, I  |e verfasserin  |4 aut 
700 1 |a Molina, A  |e verfasserin  |4 aut 
700 1 |a Ayling, C  |e verfasserin  |4 aut 
700 1 |a Davies, S L  |e verfasserin  |4 aut 
700 1 |a Zou, X  |e verfasserin  |4 aut 
700 1 |a Williams, G T  |e verfasserin  |4 aut 
700 1 |a Neuberger, M S  |e verfasserin  |4 aut 
700 1 |a Brüggemann, M  |e verfasserin  |4 aut 
700 1 |a Gambón, F  |e verfasserin  |4 aut 
700 1 |a Diaz-Espada, F  |e verfasserin  |4 aut 
700 1 |a González-Fernandez, A  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t BioTechniques  |d 1991  |g 33(2002), 3 vom: 11. Sept., Seite 680, 682, 684 passim  |w (DE-627)NLM012627046  |x 1940-9818  |7 nnas 
773 1 8 |g volume:33  |g year:2002  |g number:3  |g day:11  |g month:09  |g pages:680, 682, 684 passim 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_21 
912 |a GBV_ILN_22 
912 |a GBV_ILN_39 
912 |a GBV_ILN_40 
912 |a GBV_ILN_50 
912 |a GBV_ILN_60 
912 |a GBV_ILN_62 
912 |a GBV_ILN_65 
912 |a GBV_ILN_70 
912 |a GBV_ILN_99 
912 |a GBV_ILN_121 
912 |a GBV_ILN_130 
912 |a GBV_ILN_227 
912 |a GBV_ILN_350 
912 |a GBV_ILN_618 
912 |a GBV_ILN_640 
912 |a GBV_ILN_754 
912 |a GBV_ILN_2001 
912 |a GBV_ILN_2002 
912 |a GBV_ILN_2003 
912 |a GBV_ILN_2005 
912 |a GBV_ILN_2006 
912 |a GBV_ILN_2007 
912 |a GBV_ILN_2008 
912 |a GBV_ILN_2009 
912 |a GBV_ILN_2010 
912 |a GBV_ILN_2012 
912 |a GBV_ILN_2015 
912 |a GBV_ILN_2018 
912 |a GBV_ILN_2023 
912 |a GBV_ILN_2035 
912 |a GBV_ILN_2040 
912 |a GBV_ILN_2060 
912 |a GBV_ILN_2099 
912 |a GBV_ILN_2105 
912 |a GBV_ILN_2121 
912 |a GBV_ILN_2470 
951 |a AR 
952 |d 33  |j 2002  |e 3  |b 11  |c 09  |h 680, 682, 684 passim